| Application no. and date | 19732174.8 (espacenet) (Federated) (European Patent Register), 20190530 | | Patent/reg. no. and date | DK/EP 3710485, 20210331 | | Publication date | 20200923 | | Priority no. and date | US 201862678061 P, 20180530 | | EP pub. no. and date |
EP 3710485 20200923 | | Effective date | | | Applicant/owner | AbbVie Stemcentrx LLC, 1 North Waukegan Road
North Chicago, Illinois 60064, US | | Applicant ref. no. | V2104-002-DK | | Inventor | LIU, David, 495 Loma Vista Terrace
Pacifica, California 94044, US,
SCHAMMEL, Alexander, 25 Glendale Street, Apt. 3
San Francisco, California 94114, US,
GAVRILYUK, Julia, 3525 Del Mar Heights Road, 1855
San Diego,CA 92130, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 47/68 (2017.01) , C07K 16/28 (2006.01) | | Title | ANTI-SEZ6-ANTISTOF-LÆGEMIDDELKONJUGATER OG ANVENDELSESFREMGANGSMÅDER | | Int. application no. | US2019034701 | | Int. publication no. | WO2019232241 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
